Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “JAK Inhibitor”

209 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 209 results

Not applicableLooking for participantsNCT07261891
What this trial is testing

Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders

Who this might be right for
Primary Immunodeficiency Diseases (PID)
prof. dr. Rik Schrijvers 20
Testing effectiveness (Phase 2)Looking for participantsNCT06887803
What this trial is testing

Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors

Who this might be right for
Myelofibrosis (MF)
iOnctura 26
Testing effectiveness (Phase 2)UnknownNCT04640532
What this trial is testing

KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF

Who this might be right for
MyelofibrosisPost-PV MFPost-ET Myelofibrosis+1 more
Kartos Therapeutics, Inc. 116
Post-approval studies (Phase 4)WithdrawnNCT04330495
What this trial is testing

Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection

Who this might be right for
COVID 19Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors
Instituto de Investigación Marqués de Valdecilla
Testing effectiveness (Phase 2)Study completedNCT05906628
What this trial is testing

Topical Ruxolitinib Evaluation in Chronic Hand Eczema

Who this might be right for
Hand Eczema
Incyte Corporation 186
Not applicableLooking for participantsNCT06976918
What this trial is testing

Research Platform Myelofibrosis and Anemia

Who this might be right for
Primary MyelofibrosisSecondary MyelofibrosisPost-polycythemia Vera Myelofibrosis+4 more
iOMEDICO AG 200
Testing effectiveness (Phase 2)WithdrawnNCT07012057
What this trial is testing

Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis

Who this might be right for
MyositisDermatomyositis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Not applicableLooking for participantsNCT05456412
What this trial is testing

JAK Inhibition in Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Leiden University Medical Center 60
Not applicableEnrolling By InvitationNCT06999941
What this trial is testing

A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features

Who this might be right for
PsoriasisEczemaJAK Inhibitor
Xi Tan 50
Not applicableActive Not RecruitingNCT05387980
What this trial is testing

Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Pfizer 1,128
Not applicableLooking for participantsNCT06691061
What this trial is testing

The PODIUM Study - a Three-arm Comparison of Target Therapies After Anti-TNFα in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (Disorder)
Humanitas Clinical and Research Center 450
Testing effectiveness (Phase 2)Study completedNCT05016297
What this trial is testing

Efficacy and Safety of Baricitinib in Sjogren's Syndrome

Who this might be right for
Sjogren's Syndrome
Peking Union Medical College Hospital 87
Large-scale testing (Phase 3)Study completedNCT00934544
What this trial is testing

Controlled Myelofibrosis Study With Oral Janus-associated Kinase (JAK) Inhibitor Treatment-II: The COMFORT-II Trial

Who this might be right for
Myelofibrosis
Novartis Pharmaceuticals 219
Testing effectiveness (Phase 2)Study completedNCT03569371
What this trial is testing

The Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
Incyte Corporation 10
Testing effectiveness (Phase 2)Ended earlyNCT03635112
What this trial is testing

Efficacy and Safety of TD-1473 in Crohn's Disease

Who this might be right for
Crohn's Disease
Theravance Biopharma 167
Early research (Phase 1)Study completedNCT04769869
What this trial is testing

A Clinical Trial in Healthy Volunteers and Patients With Mild Asthma to Investigate a New Medicine (AZD4604) for the Treatment of Asthma

Who this might be right for
Asthma
AstraZeneca 110
Early research (Phase 1)Study completedNCT02531191
What this trial is testing

Bioequivalence Evaluation of a New and Current Tablet of ASP015K

Who this might be right for
Healthy Volunteers
Astellas Pharma Inc 40
Not applicableLooking for participantsNCT06977035
What this trial is testing

Nerve Conduction Study for Assessment of Peripheral Neuropathy in Rheumatoid Arthritis Patients on the Janus Kinase Inhibitor Baricitinib

Who this might be right for
Rheumatoid Arthritis
Sohag University 60
Testing effectiveness (Phase 2)Study completedNCT04896385
What this trial is testing

Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA)

Who this might be right for
Vitiligo
Incyte Corporation 60
Early research (Phase 1)Ended earlyNCT03320642
What this trial is testing

GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

Who this might be right for
Hematologic Malignancies
Incyte Corporation 84
Load More Results